Skip to main content
Erschienen in: Medical Oncology 3/2017

01.03.2017 | Original Paper

Intravoxel Incoherent Motion (IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer Detection and Stratification

verfasst von: Filippo Pesapane, Francesca Patella, Enrico Maria Fumarola, Silvia Panella, Anna Maria Ierardi, Giovanni Guido Pompili, Giuseppe Franceschelli, Salvatore Alessio Angileri, Alberto Magenta Biasina, Gianpaolo Carrafiello

Erschienen in: Medical Oncology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to compare the Intravoxel Incoherent Motion (IVIM) parameters between healthy Peripheral Zone (PZ), Benign Prostatic Hyperplasia (BPH) and Prostate Cancer (PCa) and compare them to assess whether there was correlation with Gleason Score (GS) grading system. Thirty-one patients with suspect of PCa underwent 1.5T Multi-Parametric Magnetic Resonance Imaging (MP-MRI) with endorectal coil with a protocol including T2WI, DWI using 10 b values (0, 10, 20, 30, 50, 80, 100, 200, 400, 1000 s/mm2) and DCE. Monoexponential and IVIM model fits were used to calculate both apparent diffusion coefficient (ADC) and the following IVIM parameters: molecular diffusion coefficient (D), perfusion-related diffusion coefficient (D*) and perfusion fraction (f). The ADC and D values were significantly lower in the PCa (0.70 ± 0.16 × 10−3 mm2/s and 0.88 ± 0.31 × 10−3 mm2/s) compared to those found in the PZ (1.22 ± 0.20 × 10−3 mm2/s and 1.78 ± 0.34 × 10−3 mm2/s) and in the BPH (1.53 ± 0.23 × 10−3 mm2/s and 1.11 ± 0.28 × 10−3 mm2/s). The D* parameter was significantly increased in the PCa (5.35 ± 5.12 × 10−3 mm2/s) compare to the healthy PZ (3.02 ± 2.86 × 10−3 mm2/s), instead there was not significantly difference in the PCa compare to the BPH (5.61 ± 6.77 × 10−3 mm2/s). The f was statistically lower in the PCa (9.01 ± 5.20%) compared to PZ (10.57 ± 9.30%), but not significantly different between PCa and BPH (9.29 ± 7.29%). The specificity, sensitivity and accuracy of T2WI associated with DWI and IVIM were higher (100, 98 and 99%, respectively) than for T2WI/DWI and IVIM alone (89, 92 and 90%, respectively). Only for ADC was found a statistical difference between low- and intermediate-/high-grade tumors. Adding IVIM to the MP-MRI could increase the diagnostic performance to detect clinically relevant PCa. ADC values have been found to have a rule to discriminate PCa reliably from normal areas and differed significantly in low- and intermediate-/high-grade PCa. In contrast, IVIM parameters were unable to distinguish between the different GS.
Literatur
1.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, et al. Global cancer statistics. CA Cancer J Clin. 2015;65(2):87–108.CrossRefPubMed Torre LA, Bray F, Siegel RL, et al. Global cancer statistics. CA Cancer J Clin. 2015;65(2):87–108.CrossRefPubMed
2.
Zurück zum Zitat Kurhanewicz J, Vigneron D, Carroll P, Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol. 2008;18(1):71–7.CrossRefPubMedPubMedCentral Kurhanewicz J, Vigneron D, Carroll P, Coakley F. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol. 2008;18(1):71–7.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Mottet N, Bellmunt J, Bolla M, et al. EAU–ESTRO–SIOG guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2016;S0302–2838(16):30470–5. Mottet N, Bellmunt J, Bolla M, et al. EAU–ESTRO–SIOG guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2016;S0302–2838(16):30470–5.
4.
Zurück zum Zitat Pinto PA, Chung PH, Rastinehad AR, et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol. 2011;186(4):1281–5.CrossRefPubMedPubMedCentral Pinto PA, Chung PH, Rastinehad AR, et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol. 2011;186(4):1281–5.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Hambrock T, Hoeks C, Hulsbergen-van de Kaa C, et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging—guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol. 2012;61:177–84.CrossRefPubMed Hambrock T, Hoeks C, Hulsbergen-van de Kaa C, et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging—guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol. 2012;61:177–84.CrossRefPubMed
6.
Zurück zum Zitat Vargas HA, Akin O, Franiel T, et al. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology. 2011;259:775–84.CrossRefPubMedPubMedCentral Vargas HA, Akin O, Franiel T, et al. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology. 2011;259:775–84.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Turkbey B, Shah VP, Pang Y, et al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-TMR images. Radiology. 2011;258:488–95.CrossRefPubMedPubMedCentral Turkbey B, Shah VP, Pang Y, et al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-TMR images. Radiology. 2011;258:488–95.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging-reporting and data system: 2015, version 2, Eur Urol. 2016;69(1):16–40. Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS prostate imaging-reporting and data system: 2015, version 2, Eur Urol. 2016;69(1):16–40.
9.
Zurück zum Zitat Panebianco F, Barchetti V, Sciarra A, et al. Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol. 2015;33:1–7.CrossRef Panebianco F, Barchetti V, Sciarra A, et al. Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study. Urol Oncol. 2015;33:1–7.CrossRef
10.
Zurück zum Zitat Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11(2):102–25.CrossRefPubMedPubMedCentral Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11(2):102–25.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505.CrossRefPubMed Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497–505.CrossRefPubMed
12.
Zurück zum Zitat Le Bihan D, Breton E, Lallemand D. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401–7.CrossRefPubMed Le Bihan D, Breton E, Lallemand D. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401–7.CrossRefPubMed
13.
Zurück zum Zitat Kuru TH, Roethke MC, Stieltjes B, et al. Intravoxel incoherent motion (IVIM) diffusion imaging in prostate cancer-what does it add? J Comput Assist Tomogr. 2014;38(4):558–64.CrossRefPubMed Kuru TH, Roethke MC, Stieltjes B, et al. Intravoxel incoherent motion (IVIM) diffusion imaging in prostate cancer-what does it add? J Comput Assist Tomogr. 2014;38(4):558–64.CrossRefPubMed
14.
Zurück zum Zitat Döpfert JLA, Weidner A, Schad LR. Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging. Magn Reson Imaging. 2011;29(8):1053–8.CrossRefPubMed Döpfert JLA, Weidner A, Schad LR. Investigation of prostate cancer using diffusion-weighted intravoxel incoherent motion imaging. Magn Reson Imaging. 2011;29(8):1053–8.CrossRefPubMed
15.
Zurück zum Zitat Riches SF, Hawtin K, Charles-Edwards EM, de Souza NM. Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients. NMR Biomed. 2009;22(3):318–25.CrossRefPubMed Riches SF, Hawtin K, Charles-Edwards EM, de Souza NM. Diffusion-weighted imaging of the prostate and rectal wall: comparison of biexponential and monoexponential modelled diffusion and associated perfusion coefficients. NMR Biomed. 2009;22(3):318–25.CrossRefPubMed
16.
Zurück zum Zitat Mazaheri Y, Vargas HA, Akin O, et al. Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting. J Magn Reson Imaging. 2012;35(3):660–8.CrossRefPubMed Mazaheri Y, Vargas HA, Akin O, et al. Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting. J Magn Reson Imaging. 2012;35(3):660–8.CrossRefPubMed
17.
Zurück zum Zitat Xu J, Humphrey PA, Kibel AS, et al. Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med. 2009;61(4):842–50.CrossRefPubMedPubMedCentral Xu J, Humphrey PA, Kibel AS, et al. Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med. 2009;61(4):842–50.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Ocak I, Bernardo M, Metzger G, et al. Dynamic contrastenhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol. 2007;189(4):849.CrossRefPubMed Ocak I, Bernardo M, Metzger G, et al. Dynamic contrastenhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol. 2007;189(4):849.CrossRefPubMed
19.
Zurück zum Zitat McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med. 2003;9(6):713–25.CrossRefPubMed McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med. 2003;9(6):713–25.CrossRefPubMed
20.
Zurück zum Zitat Prince MR, Zhang HL, Roditi GH, et al. Risk factors for NSF: a literature review. J Magn Reson Imaging. 2009;30(6):1298–308.CrossRefPubMed Prince MR, Zhang HL, Roditi GH, et al. Risk factors for NSF: a literature review. J Magn Reson Imaging. 2009;30(6):1298–308.CrossRefPubMed
21.
Zurück zum Zitat Kuru TH, Roethke MC, Seidenader J, et al. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol. 2013;190:1380–6.CrossRefPubMed Kuru TH, Roethke MC, Seidenader J, et al. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol. 2013;190:1380–6.CrossRefPubMed
22.
Zurück zum Zitat Matoso A, Epstein JI. Grading of prostate cancer: past, present, and future. Curr Urol Rep. 2016;17(3):25.CrossRefPubMed Matoso A, Epstein JI. Grading of prostate cancer: past, present, and future. Curr Urol Rep. 2016;17(3):25.CrossRefPubMed
23.
Zurück zum Zitat Anderson TW. An introduction to multivariate statistical analysis. 2nd ed. New York: Wiley; 1984. Anderson TW. An introduction to multivariate statistical analysis. 2nd ed. New York: Wiley; 1984.
24.
Zurück zum Zitat Koh DM, Collins DJ. Diffusion-weighted mri in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622–35.CrossRefPubMed Koh DM, Collins DJ. Diffusion-weighted mri in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007;188:1622–35.CrossRefPubMed
25.
Zurück zum Zitat Tanimoto A, Nakashima J, Kohno H, et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging. 2007;25:146–52.CrossRefPubMed Tanimoto A, Nakashima J, Kohno H, et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging. 2007;25:146–52.CrossRefPubMed
26.
Zurück zum Zitat Pang Y, Turkbey B, Bernardo M, et al. Intravoxel incoherent motion (IVIM) MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med. 2013;69(2):553–62.CrossRefPubMed Pang Y, Turkbey B, Bernardo M, et al. Intravoxel incoherent motion (IVIM) MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med. 2013;69(2):553–62.CrossRefPubMed
27.
Zurück zum Zitat Valerio M, Zini C, Fierro D, et al. 3T multiparametric MRI of the prostate: does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone? Eur J Radiol. 2016;85(4):790–4.CrossRefPubMed Valerio M, Zini C, Fierro D, et al. 3T multiparametric MRI of the prostate: does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone? Eur J Radiol. 2016;85(4):790–4.CrossRefPubMed
28.
Zurück zum Zitat Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging—pilot study. Radiology. 2008;249:891–9.CrossRefPubMed Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging—pilot study. Radiology. 2008;249:891–9.CrossRefPubMed
29.
Zurück zum Zitat Le Bihan D. Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology. 2008;249(3):748–52.CrossRefPubMed Le Bihan D. Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology. 2008;249(3):748–52.CrossRefPubMed
30.
Zurück zum Zitat Shinmoto H, Tamura C, Soga S, et al. An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer. AJR Am J Roentgenol. 2012;199(4):W496–500.CrossRefPubMed Shinmoto H, Tamura C, Soga S, et al. An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer. AJR Am J Roentgenol. 2012;199(4):W496–500.CrossRefPubMed
31.
Zurück zum Zitat Shinmoto H, Oshio K, Tanimoto A, Higuchi N, Okuda S, Kuribayashi S, Mulkern RV. Biexponential apparent diffusion coefficients in prostate cancer. Magn Reson Imaging. 2009;27(3):355–9.CrossRefPubMed Shinmoto H, Oshio K, Tanimoto A, Higuchi N, Okuda S, Kuribayashi S, Mulkern RV. Biexponential apparent diffusion coefficients in prostate cancer. Magn Reson Imaging. 2009;27(3):355–9.CrossRefPubMed
32.
Zurück zum Zitat Mulkern RV, Barnes AS, Haker SJ, Hung YP, Rybicki FJ, Maier SE, Tempany CM. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging. 2006;24(5):563–8.CrossRefPubMedPubMedCentral Mulkern RV, Barnes AS, Haker SJ, Hung YP, Rybicki FJ, Maier SE, Tempany CM. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging. 2006;24(5):563–8.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Le Bihan D, Turner R. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med. 1992;27:171–8.CrossRefPubMed Le Bihan D, Turner R. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med. 1992;27:171–8.CrossRefPubMed
34.
Zurück zum Zitat Yang F, Tuxhorn JA, Ressler SJ, et al. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005;65(19):8887–95.CrossRefPubMed Yang F, Tuxhorn JA, Ressler SJ, et al. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res. 2005;65(19):8887–95.CrossRefPubMed
35.
Zurück zum Zitat Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol. 2007;63(3):335–50.CrossRefPubMed Alonzi R, Padhani AR, Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol. 2007;63(3):335–50.CrossRefPubMed
36.
Zurück zum Zitat Franiel T, Lüdemann L, Rudolph B, et al. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion prepared dual-contrast gradient echo sequence. Invest Radiol. 2008;43:481–7.CrossRefPubMed Franiel T, Lüdemann L, Rudolph B, et al. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion prepared dual-contrast gradient echo sequence. Invest Radiol. 2008;43:481–7.CrossRefPubMed
37.
Zurück zum Zitat Patel J, Sigmund EE, Rusinek H, et al. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging. 2010;31:589–600.CrossRefPubMedPubMedCentral Patel J, Sigmund EE, Rusinek H, et al. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging. 2010;31:589–600.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Dennis LK, Lynch CF, Torner JC. Epidemiologic association between prostatitis and prostate cancer. Urology. 2002;60:78–83.CrossRefPubMed Dennis LK, Lynch CF, Torner JC. Epidemiologic association between prostatitis and prostate cancer. Urology. 2002;60:78–83.CrossRefPubMed
39.
Zurück zum Zitat Koh DM, Blackledge M, Collins DJ, et al. Reproducibility and changes in the apparent diffusion coefficients of solid tumors treated with combretastatin A4 phosphate and bevacizumab in a twocentre phase I clinical trial. Eur Radiol. 2009;19:2728–38.CrossRefPubMed Koh DM, Blackledge M, Collins DJ, et al. Reproducibility and changes in the apparent diffusion coefficients of solid tumors treated with combretastatin A4 phosphate and bevacizumab in a twocentre phase I clinical trial. Eur Radiol. 2009;19:2728–38.CrossRefPubMed
40.
Zurück zum Zitat Wagner B, Drel V, Gorin Y. Pathophysiology of gadolinium-associated systemic fibrosis. Am J Physiol Renal Physiol. 2016;311(1):F1–11.CrossRefPubMed Wagner B, Drel V, Gorin Y. Pathophysiology of gadolinium-associated systemic fibrosis. Am J Physiol Renal Physiol. 2016;311(1):F1–11.CrossRefPubMed
Metadaten
Titel
Intravoxel Incoherent Motion (IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer Detection and Stratification
verfasst von
Filippo Pesapane
Francesca Patella
Enrico Maria Fumarola
Silvia Panella
Anna Maria Ierardi
Giovanni Guido Pompili
Giuseppe Franceschelli
Salvatore Alessio Angileri
Alberto Magenta Biasina
Gianpaolo Carrafiello
Publikationsdatum
01.03.2017
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 3/2017
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-017-0892-7

Weitere Artikel der Ausgabe 3/2017

Medical Oncology 3/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.